Batoclimab as induction and maintenance therapy in patients with myasthenia gravis: rationale and study design of a phase 3 clinical trial

ABSTRACT:

SUBMITTER: Benatar M 

PROVIDER: S-EPMC10806862 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature